We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Looking to Divest Products Ahead of Allergan Generics Deal
Teva Looking to Divest Products Ahead of Allergan Generics Deal
Teva Pharmaceuticals is trying to divest assets in anticipation of regulatory objections to its purchase of Allergan’s generics division, according to a corporate filing.